• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿病患者的神经生长因子和硝化应激。

NGF and nitrosative stress in patients with Huntington's disease.

机构信息

Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)/Universidad de Córdoba, Córdoba, Spain.

出版信息

J Neurol Sci. 2012 Apr 15;315(1-2):133-6. doi: 10.1016/j.jns.2011.12.014. Epub 2012 Jan 16.

DOI:10.1016/j.jns.2011.12.014
PMID:22251933
Abstract

INTRODUCTION

Huntington's disease (HD) is a neurodegenerative genetic disorder caused by expansion of polyglutamine repeats in the huntingtin gene and characterised by the loss of striatal and cortical neurons. Few studies to date have focussed on peripheral neurotrophic-factor levels in patients with HD.

OBJECTIVE

To measure plasma NGF levels in Huntington's disease and investigate their correlation with disease intensity.

MATERIALS AND METHODS

Nineteen patients with HD and nineteen age- and sex-matched healthy subjects took part in this cross-sectional study. Plasma levels of NGF, BDNF, GDNF, nitrotyrosine, and myeloperoxidase (MPO) were measured; lactate dehydrogenase (LDH) levels were determined and white blood cell (WBC) counts were evaluated.

RESULTS

NGF levels were significantly lower, nitrotyrosine levels were higher and LDH activity was greater in HD patients than in healthy subjects. There was no significant difference in MPO levels or WBC counts, whereas the MPO/WBC ratio was considerably higher in HD patients. The data obtained suggested that biochemical and haematological changes correlated with disease severity.

CONCLUSION

NGF levels are lower in HD patients than in healthy subjects. However, further research is required to confirm the role of NGF in HD.

摘要

简介

亨廷顿病(HD)是一种由亨廷顿基因中多聚谷氨酰胺重复扩展引起的神经退行性遗传疾病,其特征是纹状体和皮质神经元的丧失。迄今为止,很少有研究关注亨廷顿病患者外周神经营养因子水平。

目的

测量亨廷顿病患者的血浆 NGF 水平,并探讨其与疾病严重程度的相关性。

材料和方法

本横断面研究纳入了 19 名亨廷顿病患者和 19 名年龄和性别匹配的健康对照者。测量了血浆 NGF、BDNF、GDNF、硝基酪氨酸和髓过氧化物酶(MPO)水平;测定了乳酸脱氢酶(LDH)水平,并评估了白细胞(WBC)计数。

结果

与健康对照组相比,亨廷顿病患者的 NGF 水平显著降低,硝基酪氨酸水平升高,LDH 活性更高。MPO 水平或 WBC 计数无显著差异,而 MPO/WBC 比值在亨廷顿病患者中显著升高。数据表明生化和血液学变化与疾病严重程度相关。

结论

亨廷顿病患者的 NGF 水平低于健康对照组。然而,需要进一步研究来证实 NGF 在亨廷顿病中的作用。

相似文献

1
NGF and nitrosative stress in patients with Huntington's disease.亨廷顿病患者的神经生长因子和硝化应激。
J Neurol Sci. 2012 Apr 15;315(1-2):133-6. doi: 10.1016/j.jns.2011.12.014. Epub 2012 Jan 16.
2
Plasma testosterone in male patients with Huntington's disease: relations to severity of illness and dementia.男性亨廷顿舞蹈症患者的血浆睾酮水平:与疾病严重程度和痴呆症的关系
Ann Neurol. 2005 Apr;57(4):520-5. doi: 10.1002/ana.20428.
3
Oxidative stress and inflammation biomarkers in the blood of patients with Huntington's disease.亨廷顿舞蹈症患者血液中的氧化应激和炎症生物标志物
Neurol Res. 2012 Sep;34(7):721-4. doi: 10.1179/1743132812Y.0000000073.
4
Oxidative and nitrosative stress markers in patients on hemodialysis and peritoneal dialysis.血液透析和腹膜透析患者的氧化应激和硝化应激标志物。
Blood Purif. 2011;32(3):202-8. doi: 10.1159/000328030. Epub 2011 Jul 29.
5
Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.脑源性神经营养因子和神经生长因子与原发性干燥综合征中的T细胞活化相关。
Scand J Rheumatol. 2009 Jan-Feb;38(1):50-7. doi: 10.1080/03009740802378832.
6
Relation between plasma brain-derived neurotrophic factor and nerve growth factor in the male patients with alcohol dependence.男性酒精依赖患者血浆脑源性神经营养因子与神经生长因子的关系。
Alcohol. 2009 Jun;43(4):265-9. doi: 10.1016/j.alcohol.2009.04.003.
7
Clinical relevance of nerve growth factor serum levels in patients with atopic dermatitis and psoriasis.特应性皮炎和银屑病患者血清神经生长因子水平的临床相关性
Int Arch Allergy Immunol. 2007;144(3):211-6. doi: 10.1159/000103994. Epub 2007 Jun 18.
8
Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease: restoration by the neuroprotective compound CEP-1347.在亨廷顿舞蹈症的啮齿动物模型中,脑源性神经营养因子信使核糖核酸的血液水平逐渐降低:神经保护化合物CEP-1347可使其恢复。
Mol Cell Neurosci. 2008 Sep;39(1):1-7. doi: 10.1016/j.mcn.2008.04.012. Epub 2008 May 10.
9
Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients.亨廷顿舞蹈症患者外周血中氧化损伤增加及线粒体异常
Biochem Biophys Res Commun. 2007 Jul 27;359(2):335-40. doi: 10.1016/j.bbrc.2007.05.093. Epub 2007 May 24.
10
MR relaxometry in Huntington's disease: correlation between imaging, genetic and clinical parameters.亨廷顿舞蹈症中的磁共振弛豫测量法:影像学、遗传学与临床参数之间的相关性
J Neurol Sci. 2007 Dec 15;263(1-2):20-5. doi: 10.1016/j.jns.2007.05.018. Epub 2007 Jun 22.

引用本文的文献

1
1953-2023. Seventy Years of the Nerve Growth Factor: A Potential Novel Treatment in Neurological Diseases?1953 - 2023. 神经生长因子的七十年:神经系统疾病的一种潜在新疗法?
Aging Dis. 2024 Jul 15;16(4):2293-2314. doi: 10.14336/AD.2024.0573.
2
Brain-Derived Neurotrophic Factor (BDNF) in Huntington's Disease: Neurobiology and Therapeutic Potential.亨廷顿舞蹈症中的脑源性神经营养因子(BDNF):神经生物学与治疗潜力
Curr Neuropharmacol. 2025;23(4):384-403. doi: 10.2174/1570159X22666240530105516.
3
Advances in Huntington's Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive Review.
亨廷顿舞蹈症生物标志物的进展:十年文献计量分析与综合综述
Biology (Basel). 2025 Jan 26;14(2):129. doi: 10.3390/biology14020129.
4
Growth Factors and Their Application in the Therapy of Hereditary Neurodegenerative Diseases.生长因子及其在遗传性神经退行性疾病治疗中的应用。
Biomedicines. 2024 Aug 20;12(8):1906. doi: 10.3390/biomedicines12081906.
5
Elevated SLC7A2 expression is associated with an abnormal neuroinflammatory response and nitrosative stress in Huntington's disease.SLC7A2 表达水平升高与亨廷顿病中的异常神经炎症反应和硝化应激有关。
J Neuroinflammation. 2024 Feb 28;21(1):59. doi: 10.1186/s12974-024-03038-2.
6
Perinatal Tissue-Derived Stem Cells: An Emerging Therapeutic Strategy for Challenging Neurodegenerative Diseases.围产期组织来源的干细胞:治疗挑战性神经退行性疾病的新兴治疗策略。
Int J Mol Sci. 2024 Jan 12;25(2):976. doi: 10.3390/ijms25020976.
7
Alterations of Plasmatic Biomarkers of Neurodegeneration in Mucopolysaccharidosis Type II Patients Under Enzyme Replacement Therapy.黏多糖贮积症 II 型患者接受酶替代治疗后神经退行性变的血浆生物标志物的改变。
Cell Biochem Biophys. 2023 Sep;81(3):533-542. doi: 10.1007/s12013-023-01149-w. Epub 2023 Jul 20.
8
The updated development of blood-based biomarkers for Huntington's disease.用于亨廷顿病的基于血液的生物标志物的最新进展。
J Neurol. 2023 May;270(5):2483-2503. doi: 10.1007/s00415-023-11572-x. Epub 2023 Jan 24.
9
Magnesium and the Brain: A Focus on Neuroinflammation and Neurodegeneration.镁与大脑:聚焦神经炎症与神经退行性变。
Int J Mol Sci. 2022 Dec 23;24(1):223. doi: 10.3390/ijms24010223.
10
Epileptic brain fluorescent imaging reveals apigenin can relieve the myeloperoxidase-mediated oxidative stress and inhibit ferroptosis.癫痫脑荧光成像显示芹菜素可缓解髓过氧化物酶介导的氧化应激并抑制铁死亡。
Proc Natl Acad Sci U S A. 2020 May 12;117(19):10155-10164. doi: 10.1073/pnas.1917946117. Epub 2020 Apr 23.